3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
3
Thoracic
2
Other hematologic neoplasm
2
Sarcoma
1
Plasma cell
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Stomach Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Interventions
Oxaliplatin
1409
Fluorouracil
1298
Capecitabine
1085
Gemcitabine
1042
Leucovorin
928
Irinotecan
815
Bevacizumab
803
Cisplatin
666
Radiotherapy
535
Cetuximab
469
pembrolizumab
428
Paclitaxel
389
Nivolumab
336
130-nm albumin-bound paclitaxel
322
Drug Therapy
314
Docetaxel
286
S 1 (combination)
273
Sorafenib
266
Folfox protocol
261
Albumin-Bound Paclitaxel
259
sintilimab
211
durvalumab
209
Surgical Procedures, Operative
203
tislelizumab
202
Radiosurgery
202
lenvatinib
201
apatinib
198
Carboplatin
186
Magnetic Resonance Spectroscopy
181
regorafenib
180
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lithium
×
Gastrointestinal
×
Clear all
NCT03153280
2025-07-08
Lithium
Cancer Trials Ireland
Phase 1
Terminated
2 enrolled